2024

1. Characterization of an outbreak caused by Elizabethkingia miricola using Fourier-transform infrared (FTIR) spectroscopy

   European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 797-803

2. Characterizing carbapenemase-producing Escherichia coli isolates from Spain: high genetic heterogeneity and wide geographical spread

   Frontiers in Cellular and Infection Microbiology, Vol. 14

3. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

   mSphere, Vol. 9, Núm. 3

4. Community Emergence of Cefixime-Resistant Escherichia coli Belonging to ST12 with Chromosomal AmpC Hyperproduction

   Antibiotics, Vol. 13, Núm. 3

5. Cytomegalovirus UL44 protein induces a potent T-cell immune response in mice

   Antiviral Research, Vol. 227

6. Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective study

   Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 29, Núm. 29

7. Diagnostic potential of combining plasma biomarkers of tissue damage and inflammation in pediatric TB

   Journal of Microbiology, Immunology and Infection

8. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

   Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

9. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

   Infection

10. Erratum to «Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper» (Archivos de Bronconeumología (2024) 60(3) (161–170), (S0300289624000061), (10.1016/j.arbres.2024.01.004))

    Archivos de Bronconeumologia

11. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

12. Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial

    Vox Sanguinis, Vol. 119, Núm. 1, pp. 27-33

13. Hospital-acquired malaria in Catalonia: an unexpected post-surgical complication

    Journal of Travel Medicine

14. IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination

    Infection, Vol. 52, Núm. 3, pp. 813-824

15. Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study

    Journal of Infection and Public Health, Vol. 17, Núm. 7

16. Immunogenicity of the Conjugate Meningococcal ACWY-TT Vaccine in Children and Adolescents Living with HIV

    Microorganisms, Vol. 12, Núm. 1

17. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine, Vol. 50, Núm. 4, pp. 502-515

18. Invasive disease caused simultaneously by two different serotypes of Streptococcus pneumoniae: a microbiological appreciation

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 5, pp. 1013-1016

19. Monkeypox virus genomic accordion strategies

    Nature Communications, Vol. 15, Núm. 1

20. Mpox, herpes, and enteroviruses: Differential diagnosis

    Journal of Medical Virology